Menu
About Us
Company Overview
Our Values
Board of Directors
Team
Scientific Advisers
Clinical Advisers
Corporate Directory
Corporate Governance
Pipeline
Clinical Trial
Investor Centre
Welcome
Investor Fact Sheet
ASX Announcements
Reports
Annual Reports
Half Yearly Reports
Quarterly Reports
Top 20 Shareholders
Research Reports
Shareholder Services
Investor FAQs
US Shareholders
Investor Newsletters
Communication
In the News
Presentations
Contact Us
Contact Us
Email Alerts
Investor Centre
Investor Centre
>
ASX Announcements
Welcome
Investor Fact Sheet
ASX Announcements
Reports
Annual Reports
Half Yearly Reports
Quarterly Reports
Top 20 Shareholders
Research Reports
Shareholder Services
Investor FAQs
US Shareholders
Investor Newsletters
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
07 Jul 2022
Change of Director's Interest Notice - Dr. Warwick Tong
05 Jul 2022
Notification of cessation of securities - ATX
30 Jun 2022
Application for quotation of securities - ATX
29 Jun 2022
Annual General Meeting to be held Thursday 25 August 2022
24 Jun 2022
Registered Office and Principal Place of Business
09 Jun 2022
Notification of Expiry of Unlisted Options
09 Jun 2022
Application for quotation of securities - ATX
02 Jun 2022
AMP945 Shows Efficacy in Model of Lung Fibrosis
30 May 2022
App 4G - Key to Corporate Governance Disclosures
30 May 2022
Corporate Governance Statement
Previous
1
2
3
4
5
6
Next
